Furthermore, administration of aerosolized SARS-CoV-2 to K18-hACE2 mice resulted solely in respiratory infection and limited clinical disease at 6 days post infection (6 dpi) in contrast with those inoculated intranasally, suggesting that severe clinical outcome in K18-hACE2 mice is attributed to CNS disease [45]. This evidence concerns the gene KRT18 and infection.